Recombinant ITGAL (Efalizumab Biosimilar) anticorps

N° du produit ABIN5668044

Détail du produit anti-ITGAL (Efalizumab Biosimilar) anticorps

Antigène: ITGAL (Efalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Blocking Reagent (BR)

Specificité: Binds to human LFA-1.

Attributs du produit:

OriginalSpeciesName: Human

OriginalFormat: IgG1

Purification: Purified antibody.

Pureté: > 98 % as determined by SDS-PAGE

niveau d'endotoxine: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogène: Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Clone: Hu1124

Isotype: IgG1 kappa

Information d'application

Indications d'application: Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

Restrictions: For Research Use only

Stockage

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur ITGAL (Efalizumab Biosimilar)

Antigène: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Produits

Synonymes: anticorps CD11A, anticorps LFA-1, anticorps LFA1A, anticorps integrin subunit alpha L, anticorps ITGAL

Classe de substances: Biosimilar

Sujet: LFA-1, integrin alpha L

UniProt: P20701